INTEGER HOLDINGS CORPORATION Net Income (Loss) Available to Common Stockholders, Diluted
INTEGER HOLDINGS CORPORATION (ITGR) reported Net Income (Loss) Available to Common Stockholders, Diluted of $66.68 million for the 12-month period ending 2017-12-29, per its 10-K filed 2018-02-22.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2018-02-22
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2014-01-03 was $9.78M.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2013-09-27 was $11.07M.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2013-06-28 was $9.75M, a 153.23% increase year-over-year.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2013-03-29 was $5.66M, a 26.77% increase year-over-year.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2017 was $66.68M, a 1018.59% increase from fiscal 2016.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2016 was $5.96M.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2016 was -$7.59M, a 113.69% decline from fiscal 2015.
- INTEGER HOLDINGS CORPORATION net income (loss) available to common stockholders, diluted for fiscal 2015 was $55.46M, a 52.92% increase from fiscal 2014.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2017-12-29 | $66.68M 10-K · filed 2018-02-22 | |||
| 2016-12-30 | $5.96M 10-K · filed 2018-02-22 | |||
| 2016-01-01 | -$7.59M 10-K · filed 2018-02-22 | |||
| 2015-01-02 | $55.46M 10-K · filed 2017-02-28 | |||
| 2014-01-03 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $20.85M derived: sum of 2 quarters · filed 2016-03-01 | $30.60M derived: sum of 3 quarters · filed 2016-03-01 | $36.27M 10-K · filed 2016-03-01 |
| 2013-09-27 | $11.07M 10-Q · filed 2013-11-05 | $20.82M derived: sum of 2 quarters · filed 2013-11-05 | $26.49M 10-Q · filed 2013-11-05 | $20.93M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-28 | $9.75M 10-Q · filed 2013-08-06 | $15.41M 10-Q · filed 2013-08-06 | $9.86M derived: sum of 3 quarters · filed 2015-03-03 | $2.30M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-29 | $5.66M 10-Q · filed 2013-05-07 | $107.00K derived: sum of 2 quarters · filed 2015-03-03 | -$7.45M derived: sum of 3 quarters · filed 2015-03-03 | -$3.60M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-28 | -$5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$13.12M derived: sum of 2 quarters · filed 2015-03-03 | -$9.27M derived: sum of 3 quarters · filed 2015-03-03 | -$4.80M 10-K · filed 2015-03-03 |
| 2012-09-28 | -$7.56M 10-Q · filed 2013-11-05 | -$3.71M derived: sum of 2 quarters · filed 2013-11-05 | $757.00K 10-Q · filed 2013-11-05 | $6.40M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-29 | $3.85M 10-Q · filed 2013-08-06 | $8.32M 10-Q · filed 2013-08-06 | $13.96M derived: sum of 3 quarters · filed 2014-03-04 | $20.95M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-30 | $4.47M 10-Q · filed 2013-05-07 | $10.11M derived: sum of 2 quarters · filed 2014-03-04 | $17.09M derived: sum of 3 quarters · filed 2014-03-04 | $25.64M derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-30 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $12.63M derived: sum of 2 quarters · filed 2014-03-04 | $21.18M derived: sum of 3 quarters · filed 2014-03-04 | $33.12M 10-K · filed 2014-03-04 |
| 2011-09-30 | $6.99M 10-Q · filed 2012-11-06 | $15.54M derived: sum of 2 quarters · filed 2012-11-06 | $27.48M 10-Q · filed 2012-11-06 | |
| 2011-07-01 | $8.55M 10-Q · filed 2012-08-07 | $20.49M 10-Q · filed 2012-08-07 | ||
| 2010-12-31 | $33.38M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |